3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
7
Myelodysplastic Syndromes
3
Wilms Tumor
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Myeloproliferative Disorders
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Glioma
2
Ependymoma
2
Xanthogranuloma, Juvenile
1
Recurrence
1
Histiocytic Sarcoma
1
Hematologic Neoplasms
1
Cholangiocarcinoma
1
Central Nervous System Neoplasms
1
Biliary Tract Neoplasms
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
pembrolizumab
19
Specimen Handling
19
Biopsy
13
Magnetic Resonance Spectroscopy
12
Carboplatin
11
Paclitaxel
10
Pemetrexed
8
Nivolumab
7
Irinotecan
7
Gemcitabine
7
trastuzumab deruxtecan
6
Fulvestrant
6
Radiosurgery
5
Leucovorin
5
Fluorouracil
5
Cisplatin
5
Cetuximab
5
Bevacizumab
5
palbociclib
4
durvalumab
4
Taxes
4
Oxaliplatin
4
Letrozole
4
Docetaxel
4
ribociclib
3
olaparib
3
Trastuzumab
3
Panitumumab
3
Midazolam
3
Ipilimumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
ivosidenib
×
30 days
×
Clear all
No trials found.